MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock under espp
$101K
Net cash provided by
(used in) financing...
$74K
Canceled cashflow
$27K
Net (decrease)
increase in cash and cash...
-$18,734K
Canceled cashflow
$74K
Stock-based compensation
expense
$3,177K
Accounts payable
$3,095K
Other liabilities
$439K
Depreciation expense
$19K
Taxes paid related to
net share...
$27K
Net cash used in
operating activities
-$18,808K
Canceled cashflow
$6,730K
Net loss
-$22,136K
Prepaid expenses and
other assets
$3,197K
Accrued liabilities
-$198K
Accretion of debt discount
on...
$7K
Back
Back
Cash Flow
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)
source: myfinsight.com